Covid-19 roundup: J&J to ap­ply for boost­er au­tho­riza­tion this week as ad­comms are set; BioN­Tech CEO Ugur Sahin pre­dicts need for new vac­cine for­mu­la­tion

Two weeks af­ter re­leas­ing new da­ta show­ing its Covid-19 boost­er shot bumped pro­tec­tion against mod­er­ate to se­vere dis­ease up to 75% world­wide, J&J is re­port­ed­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER